Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC on Acute Cognitive Effects of THC
NCT02335060Phase 1Terminated
- Sponsor
- Yale University
- Start
- May 2014
- Primary completion
- Sep 2014
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of acetylcysteine in psychosis (4 arms), sponsored by Yale University. Primary endpoint: Positive and Negative Symptom Scale. Started May 2014; status: terminated.
02
Drugs
acetylcysteine
03
Conditions
psychosis
Beyond the preview
Go deeper on NCT02335060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02335060.